References
- Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052–1057
- Ferrajoli A, O’Brien S M. Treatment of chronic lymphocytic leukemia. Semin Oncol 2004; 31(2 Suppl 4)60–65
- Brick W G, Majmundar M, Hendricks L K, Kallab A M, Burgess R E, Jillella A P. Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia. Leuk Lymphoma 2002; 43: 199–201
- Barcos M, Lane W, Gomez G A, Han T, Freeman A, Preisler H, Henderson E. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 1987; 60: 827–837
- Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, Matutes E, Milligan D, Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Br J Haematol 2004; 125: 294–317
- Marmont A M. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate. Blood 2000; 96: 776–777
- Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, Weller M. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 2004; 223: 167–178
- Remission of leukaemic meningitis after fludarabine. Lancet 1995; 346: 972
- Miller K, Budke H, Orazi A. Leukemic meningitis complicating early stage chronic lymphocytic leukemia. Arch Pathol Lab Med 1997; 5: 524–527
- Hoffman M A, Valderrama E, Fuchs A, Friedman M, Rai K. Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature. Cancer 1995; 75: 1100–1103
- Van den Bent M J, Lamers C H, van’t Veer M B, Sillevis Smitt P A, Bolhuis R L, Gratama J W. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. Ann Hematol 2002; 81: 187–191
- Nowakowski G S, Call T G, Morice W G, Kurtin P J, Cook R J, Zent C S. Clinical significance of monoclonal B cells in cerebrospinal fluid. Cytometry B Clin Cytom 2005; 63: 23–27
- Elliott M A, Letendre L, Chin-Yang L, Hoyer J, Hammack J E. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine. Br J Haematol 1999; 104: 689–694
- Cheson B D, Vena D A, Foss F M, Sorensen J M. Neurotoxicity of purine analogs: a review. J Clin Oncol 1994; 12: 2216–2228
- Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 2002; 43: 433–436
- Lindemalm S, Liliemark J, Larsson B S, Albertioni F. Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study. Med Oncol 1999; 16: 239–244